Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 1
Submit an article Journal homepage
2,163
Views
17
CrossRef citations to date
0
Altmetric
Neurology: Original articles

Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease

François VialletCentre Hospitalier du Pays d’Aix Aix-en-ProvenceFrance
,
Séverine PitelQualissima MarseilleFranceCorrespondence[email protected]
,
Sylvie LancrenonSylia Stat Bourg La ReineFrance
&
Olivier BlinCHU Timone Hospital MarseilleFrance
Pages 23-31 | Accepted 20 Nov 2012, Published online: 04 Dec 2012

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carla Schettino, Clemente Dato, Guglielmo Capaldo, Simone Sampaolo, Giuseppe Di Iorio & Mariarosa AB Melone. (2016) Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study. Neuropsychiatric Disease and Treatment 12, pages 2497-2502.
Read now

Articles from other publishers (16)

Michelle Ann C. Sy & Hubert H. Fernandez. (2020) Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD). Neurotherapeutics 17:4, pages 1331-1338.
Crossref
Xianwen Chen, Cuiping Ren, Juan Li, Shangpei Wang, Louis Dron, Ofir Harari & Craig Whittington. (2020) The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-Analysis. Clinical Neuropharmacology 43:4, pages 100-106.
Crossref
Lana Chahine. 2020. Disorders of Sleep and Wakefulness in Parkinson's Disease. Disorders of Sleep and Wakefulness in Parkinson's Disease 125 142 .
W. Schrempf, M. Fauser, M. Wienecke, S. Brown, A. Maaß, C. Ossig, K. Otto, M. D. Brandt, M. Löhle, U. Schwanebeck, X. Graehlert, H. Reichmann & A. Storch. (2018) Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial. European Journal of Neurology 25:4, pages 672-679.
Crossref
J. Andrew Albers, Pratap Chand & A. Michael Anch. (2017) Multifactorial sleep disturbance in Parkinson's disease. Sleep Medicine 35, pages 41-48.
Crossref
Chuanjun Zhuo, Xiaodong Zhu, Ronghuan Jiang, Feng Ji, Zhonghua Su, Rong Xue & Yuying Zhou. (2017) Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson’s Disease: A Network Meta-Analysis. Scientific Reports 7:1.
Crossref
Maria João Forjaz, Carmen Rodriguez-Blazquez & Pablo Martinez-Martin. 2017. Movement Disorders Curricula. Movement Disorders Curricula 165 180 .
Ramon Lugo-Sanchez & Néstor Gálvez-Jiménez. 2016. Parkinson's Disease. Parkinson's Disease 280 286 .
. 2016. Parkinson's Disease. Parkinson's Disease 231 360 .
Anette Schrag, Anna Sauerbier & Kallol Ray Chaudhuri. (2015) New clinical trials for nonmotor manifestations of Parkinson's disease. Movement Disorders 30:11, pages 1490-1504.
Crossref
Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz & Monica M. Kurtis. (2015) Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson’s Disease. CNS Drugs 29:5, pages 397-413.
Crossref
Oliver Riedel, Jens Klotsche & Hans-Ulrich Wittchen. (2014) Motor impairment, depression, dementia: Which forms the impression of disease severity in Parkinson's disease?. Parkinsonism & Related Disorders 20:12, pages 1365-1370.
Crossref
James E. Frampton. (2014) Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease. Drugs 74:18, pages 2175-2190.
Crossref
Paul L. McCormack. (2014) Rasagiline: A Review of Its Use in the Treatment of Idiopathic Parkinson’s Disease. CNS Drugs 28:11, pages 1083-1097.
Crossref
P. Cesaro & L. Defebvre. (2014) Traitement médicamenteux de la maladie de Parkinson à la phase précoce (de novo et « lune de miel »). Revue Neurologique 170:4, pages 237-246.
Crossref
Sara Mínguez-Mínguez, Julián Solís-García del Pozo & Joaquín Jordán. (2013) Rasagiline in Parkinson's disease: A review based on meta-analysis of clinical data. Pharmacological Research 74, pages 78-86.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.